Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis
Ronald Chow, James Im, Nicholas Chiu, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253576-e0253576
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
Rosemary Knight, Venexia Walker, Samantha Ip, et al.
Circulation (2022) Vol. 146, Iss. 12, pp. 892-906
Open Access | Times Cited: 220
Alterations of Lipid Profile in COVID-19: A Narrative Review
Abbas Rezaei, Sina Neshat, Kiyan Heshmat‐Ghahdarijani
Current Problems in Cardiology (2021) Vol. 47, Iss. 3, pp. 100907-100907
Open Access | Times Cited: 47
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study
Iva Selke Krulichová, Gisbert Selke, Marion Bennie, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 31, Iss. 10, pp. 1046-1055
Open Access | Times Cited: 29
The bidirectional interaction of COVID-19 infections and lipoproteins
Kenneth R. Feingold
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101751-101751
Open Access | Times Cited: 19
Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Cholesterol-lowering Drugs for High-Risk Hypercholesterolemia Patients with COVID-19 While on Paxlovid™ Therapy
Alpo Vuorio, Petri T. Kovanen, Frederick J. Raal
Future Virology (2022) Vol. 17, Iss. 10, pp. 761-765
Open Access | Times Cited: 16
Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19
Chieh-Chen Wu, An-Jen Lee, Chun-Hsien Su, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 20
Serum Adiponectin Predicts COVID-19 Severity
Vlad Pavel, U. Räth, Stephan Schmid, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1043-1043
Open Access | Times Cited: 2
The Value of Clinical Frailty Scale (CFS) as a Prognostic Tool in Predicting Mortality in COVID-19—A Retrospective Cohort Study
Magdalena Jachymek, Aleksandra Cader, Michał Ptak, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1104-1104
Open Access | Times Cited: 12
Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic
Stefania Angela Di Fusco, Antonella Spinelli, Lorenzo Castello, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 22, pp. 11882-11882
Open Access | Times Cited: 16
Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients
Mia J. Coleman, Kourtney M. Zimmerly, Xuexian O. Yang
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1425-1425
Open Access | Times Cited: 14
The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity
Yousef Rasmi, Nadia Heidari, Kevser Kübra Kırboğa, et al.
Clinical Biochemistry (2022) Vol. 104, pp. 1-12
Open Access | Times Cited: 9
Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data
Adovich S. Rivera, Omar Al-Heeti, Matthew J. Feinstein, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e085547-e085547
Open Access | Times Cited: 1
Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins
Carlos‐Alberto Gonçalves, Patrícia Sesterheim, Krista Minéia Wartchow, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 8
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia
Federica Piani, Emanuela Di Salvo, Matteo Landolfo, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 33, Iss. 1, pp. 227-231
Open Access | Times Cited: 7
Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales
Rosemary Knight, Venexia Walker, Samantha Ip, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Cost-effectiveness analysis of statins for the treatment of hospitalized COVID-19 patients
Ronald Chow, Charles B. Simone, Elizabeth Horn Prsic, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 7, pp. 2285-2290
Open Access | Times Cited: 6
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation
Shabnam Radbakhsh, Niki Katsiki, Raul D. Santos, et al.
Metabolism (2022) Vol. 132, pp. 155211-155211
Closed Access | Times Cited: 6
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
Alpo Vuorio, Petri T. Kovanen, Raúl D. Santos, et al.
Cardiology and Therapy (2021) Vol. 11, Iss. 1, pp. 1-7
Open Access | Times Cited: 5
Cholesterol and Cholesterol-Lowering Medications in COVID-19—An Unresolved Matter
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10489-10489
Open Access
Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective
Barrie Tan, Kok‐Yong Chin
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top